Exact Sciences Corporatio... (EXAS)
NASDAQ: EXAS
· Real-Time Price · USD
56.72
0.53 (0.94%)
At close: Oct 03, 2025, 3:59 PM
56.15
-1.00%
After-hours: Oct 03, 2025, 07:44 PM EDT
Exact Sciences Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 657.1M | 347.13M | 600.89M | 588.83M | 530.18M | 347.49M | 605.38M | 594.61M | 604.36M | 421.37M | 242.49M | 235.31M | 213.42M | 189.78M | 315.47M | 273.78M | 363.71M | 1.1B |
Short-Term Investments | 201.34M | 439.05M | 437.14M | 432.3M | 416.6M | 304.61M | 172.27M | 139.79M | 171.35M | 277.28M | 389.56M | 433.81M | 514.62M | 627.2M | 715M | 944.69M | 943.86M | 274.15M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 124.9M | 160.18M | 169.72M | 170.82M | 167.47M | 178.09M | 177.39M | 150.75M | 89.54M | 91.87M | 90.58M | 88.74M | 96.68M | 77.48M | 74.59M | 59.24M | 54.66M | 56.95M |
Receivables | 353.33M | 279.8M | 248.97M | 264.82M | 263.87M | 240.58M | 203.62M | 199.4M | 178.32M | 183.37M | 158.04M | 189.21M | 186.54M | 205.63M | 216.65M | 249.57M | 226.54M | 256.13M |
Inventory | 171.5M | 176.57M | 162.38M | 136.99M | 127.37M | 128.53M | 127.47M | 132.84M | 130.77M | 124.09M | 118.26M | 114.7M | 115.17M | 112.96M | 104.99M | 95.17M | 89.81M | 89.03M |
Other Current Assets | 124.59M | 127.79M | 122.05M | 110.18M | 114.47M | 99.06M | 85.63M | 81.54M | 89.13M | 85.27M | 73.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 1.51B | 1.37B | 1.57B | 1.53B | 1.45B | 1.12B | 1.19B | 1.15B | 1.17B | 1.09B | 982.26M | 1.05B | 1.1B | 1.22B | 1.43B | 1.62B | 1.67B | 1.78B |
Property-Plant & Equipment | 831.21M | 824.57M | 810.63M | 812.78M | 842.89M | 844.06M | 842.06M | 842.08M | 835.29M | 841.36M | 851.76M | 846.45M | 846.15M | 792.99M | 754.47M | 692.11M | 668.82M | 644.42M |
Goodwill & Intangibles | 3.33B | 3.36B | 3.38B | 4.23B | 4.21B | 4.23B | 4.26B | 4.28B | 4.26B | 4.28B | 4.3B | 4.32B | 4.39B | 4.4B | 4.43B | 4.29B | 4.33B | 4.26B |
Total Long-Term Assets | 4.29B | 4.34B | 4.36B | 5.22B | 5.22B | 5.26B | 5.28B | 5.27B | 5.18B | 5.21B | 5.24B | 5.26B | 5.34B | 5.28B | 5.26B | 5.04B | 5.06B | 4.96B |
Total Assets | 5.8B | 5.71B | 5.93B | 6.75B | 6.67B | 6.38B | 6.47B | 6.42B | 6.36B | 6.3B | 6.23B | 6.31B | 6.44B | 6.49B | 6.68B | 6.65B | 6.72B | 6.73B |
Account Payables | 157.32M | 142.18M | 89.57M | 97.65M | 52.98M | 60.5M | 78.82M | 73.56M | 75.08M | 86.71M | 74.92M | 63.58M | 84.17M | 66.47M | 67.83M | 41.72M | 36.59M | 34.7M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | 249.15M | 249.04M | 248.92M | 298.81M | 50M | 50M | 50M | n/a | n/a | n/a | n/a | n/a | n/a | 314.42M | 314.28M | 314.15M |
Other Current Liabilities | 16.12M | 35.34M | 223.7M | 35.8M | 37.1M | 33.45M | 262.44M | 12.69M | 33.52M | 8.78M | 211.5M | 25.05M | 25.13M | 28.85M | 214.49M | 30.16M | 42.23M | 50.63M |
Total Current Liabilities | 521.93M | 502.46M | 732.19M | 723.66M | 668.64M | 685.11M | 514.7M | 476.51M | 488.06M | 367.35M | 412.75M | 423.68M | 443.33M | 480.95M | 517.07M | 710.23M | 675.7M | 628.91M |
Long-Term Debt | 2.32B | 2.32B | 2.32B | 2.32B | 2.32B | 2.07B | 2.31B | 2.31B | 2.31B | 2.36B | 2.24B | 2.23B | 2.23B | 2.18B | 2.18B | 1.89B | 1.89B | 1.89B |
Other Long-Term Liabilities | 315.9M | 320.23M | 315.5M | 332.21M | 326.68M | 329.38M | 335.98M | 341.77M | 330.82M | 344.38M | 352.46M | 355M | 364.11M | 389.06M | 417.78M | 436.58M | 439.18M | 414.19M |
Total Long-Term Liabilities | 2.81B | 2.81B | 2.79B | 2.81B | 2.81B | 2.56B | 2.81B | 2.82B | 2.81B | 2.88B | 2.77B | 2.77B | 2.78B | 2.75B | 2.78B | 2.49B | 2.49B | 2.46B |
Total Liabilities | 3.33B | 3.31B | 3.53B | 3.54B | 3.48B | 3.24B | 3.33B | 3.3B | 3.3B | 3.25B | 3.18B | 3.2B | 3.23B | 3.23B | 3.3B | 3.2B | 3.17B | 3.09B |
Total Debt | 2.52B | 2.52B | 2.75B | 2.76B | 2.76B | 2.56B | 2.55B | 2.56B | 2.56B | 2.56B | 2.45B | 2.45B | 2.45B | 2.38B | 2.38B | 2.38B | 2.38B | 2.37B |
Book Value | 2.47B | 2.4B | 2.4B | 3.21B | 3.19B | 3.13B | 3.15B | 3.12B | 3.06B | 3.06B | 3.04B | 3.11B | 3.21B | 3.26B | 3.39B | 3.46B | 3.56B | 3.65B |
Book Value Per Share | 13.07 | 12.83 | 12.96 | 17.37 | 17.32 | 17.18 | 17.37 | 17.28 | 16.96 | 17.12 | 17.14 | 17.56 | 18.20 | 18.73 | 19.64 | 20.10 | 20.75 | 21.54 |
Common Stock | 1.89M | 1.89M | 1.86M | 1.85M | 1.85M | 1.84M | 1.81M | 1.81M | 1.81M | 1.8M | 1.78M | 1.77M | 1.77M | 1.76M | 1.74M | 1.72M | 1.72M | 1.71M |
Retained Earnings | -4.6B | -4.6B | -4.5B | -3.63B | -3.6B | -3.58B | -3.47B | -3.42B | -3.42B | -3.34B | -3.27B | -3.14B | -2.99B | -2.82B | -2.64B | -2.42B | -2.25B | -2.08B |
Comprehensive Income | 3.09M | 1.01M | -944K | 4.63M | -943K | -499K | 1.43M | -1.53M | -723K | -1.72M | -5.24M | -11.07M | -8.64M | -6.65M | -1.44M | 133K | 67K | 364K |
Shareholders Equity | 2.47B | 2.4B | 2.4B | 3.21B | 3.19B | 3.13B | 3.15B | 3.12B | 3.06B | 3.06B | 3.04B | 3.11B | 3.21B | 3.26B | 3.39B | 3.46B | 3.56B | 3.65B |
Total Investments | 201.34M | 439.05M | 437.14M | 432.3M | 416.6M | 304.61M | 172.27M | 139.79M | 171.35M | 277.28M | 389.56M | 433.81M | 514.62M | 627.2M | 715M | 944.69M | 943.86M | 274.15M |